APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ophthalmic AAV Gene Therapy

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ophthalmic AAV Gene Therapy Industry Growth and Trends Forecast to 2032

26 December 202564 pages

Choose your research edition.

Industry ResearchOphthalmic AAV Gene Therapy Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Ophthalmic AAV Gene Therapy Industry Growth and Trends Forecast to 203264 pages · $3,450 USDMarket StructureGlobal Ophthalmic AAV Gene Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ophthalmic AAV Gene Therapy Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Ophthalmic AAV Gene Therapy Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

According to APO Research, the global Ophthalmic AAV Gene Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ophthalmic AAV Gene Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ophthalmic AAV Gene Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ophthalmic AAV Gene Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Ophthalmic AAV Gene Therapy market include GenSight Biologics (Pipeline) and Spark/Roche (Luxturna) among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ophthalmic AAV Gene Therapy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ophthalmic AAV Gene Therapy market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ophthalmic AAV Gene Therapy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ophthalmic AAV Gene Therapy.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Ophthalmic AAV Gene Therapy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ophthalmic AAV Gene Therapy Market by Company

GenSight Biologics (Pipeline)

Spark/Roche (Luxturna)

Ophthalmic AAV Gene Therapy Segment by Type

Subretinal Injection

Intravitreous Injection

Ophthalmic AAV Gene Therapy Segment by Application

Retinopathy

Optic Atrophy

Ophthalmic AAV Gene Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic AAV Gene Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic AAV Gene Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic AAV Gene Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Ophthalmic AAV Gene Therapy companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Ophthalmic AAV Gene Therapy Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Ophthalmic AAV Gene Therapy Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Ophthalmic AAV Gene Therapy Market Share by Region (2021-2026) Table 4. Global Ophthalmic AAV Gene Therapy Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Ophthalmic AAV Gene Therapy Market Share by Region (2027-2032) Table 6. Global Ophthalmic AAV Gene Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Ophthalmic AAV Gene Therapy Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Ophthalmic AAV Gene Therapy Market Size Share by Type (2021-2026) Table 9. Global Ophthalmic AAV Gene Therapy Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Ophthalmic AAV Gene Therapy Market Size Share Forecasted by Type (2027-2032) Table 11. North America Ophthalmic AAV Gene Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Ophthalmic AAV Gene Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Ophthalmic AAV Gene Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Ophthalmic AAV Gene Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Ophthalmic AAV Gene Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Ophthalmic AAV Gene Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Ophthalmic AAV Gene Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Ophthalmic AAV Gene Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Ophthalmic AAV Gene Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Ophthalmic AAV Gene Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Ophthalmic AAV Gene Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Ophthalmic AAV Gene Therapy Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Ophthalmic AAV Gene Therapy Market Size Share by Application (2021-2026) Table 24. Global Ophthalmic AAV Gene Therapy Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Ophthalmic AAV Gene Therapy Market Size Share Forecasted by Application (2027-2032) Table 26. North America Ophthalmic AAV Gene Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Ophthalmic AAV Gene Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Ophthalmic AAV Gene Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Ophthalmic AAV Gene Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Ophthalmic AAV Gene Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Ophthalmic AAV Gene Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Ophthalmic AAV Gene Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Ophthalmic AAV Gene Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Ophthalmic AAV Gene Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Ophthalmic AAV Gene Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Ophthalmic AAV Gene Therapy Industry Trends Table 37. Ophthalmic AAV Gene Therapy Industry Drivers Table 38. Ophthalmic AAV Gene Therapy Industry Opportunities and Challenges Table 39. Ophthalmic AAV Gene Therapy Industry Restraints Table 40. Global Ophthalmic AAV Gene Therapy Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Ophthalmic AAV Gene Therapy Revenue Market Share by Company (2021-2026) Table 42. Global Ophthalmic AAV Gene Therapy Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Ophthalmic AAV Gene Therapy Key Company Headquarters & Area Served Table 44. Global Ophthalmic AAV Gene Therapy Company, Product Type & Application Table 45. Global Ophthalmic AAV Gene Therapy Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Ophthalmic AAV Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. GenSight Biologics (Pipeline) Company Information Table 49. GenSight Biologics (Pipeline) Business Overview Table 50. GenSight Biologics (Pipeline) Ophthalmic AAV Gene Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. GenSight Biologics (Pipeline) Ophthalmic AAV Gene Therapy Product Portfolio Table 52. GenSight Biologics (Pipeline) Recent Development Table 53. Spark/Roche (Luxturna) Company Information Table 54. Spark/Roche (Luxturna) Business Overview Table 55. Spark/Roche (Luxturna) Ophthalmic AAV Gene Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Spark/Roche (Luxturna) Ophthalmic AAV Gene Therapy Product Portfolio Table 57. Spark/Roche (Luxturna) Recent Development Table 58. North America Ophthalmic AAV Gene Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 59. North America Ophthalmic AAV Gene Therapy Market Size by Country (2021-2026) & (US$ Million) Table 60. North America Ophthalmic AAV Gene Therapy Market Share by Country (2021-2026) Table 61. North America Ophthalmic AAV Gene Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 62. North America Ophthalmic AAV Gene Therapy Market Share Forecast by Country (2027-2032) Table 63. Europe Ophthalmic AAV Gene Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 64. Europe Ophthalmic AAV Gene Therapy Market Size by Country (2021-2026) & (US$ Million) Table 65. Europe Ophthalmic AAV Gene Therapy Market Share by Country (2021-2026) Table 66. Europe Ophthalmic AAV Gene Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 67. Europe Ophthalmic AAV Gene Therapy Market Share Forecast by Country (2027-2032) Table 68. Asia-Pacific Ophthalmic AAV Gene Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 69. Asia-Pacific Ophthalmic AAV Gene Therapy Market Size by Country (2021-2026) & (US$ Million) Table 70. Asia-Pacific Ophthalmic AAV Gene Therapy Market Share by Country (2021-2026) Table 71. Asia-Pacific Ophthalmic AAV Gene Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 72. Asia-Pacific Ophthalmic AAV Gene Therapy Market Share Forecast by Country (2027-2032) Table 73. Latin America Ophthalmic AAV Gene Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 74. Latin America Ophthalmic AAV Gene Therapy Market Size by Country (2021-2026) & (US$ Million) Table 75. Latin America Ophthalmic AAV Gene Therapy Market Share by Country (2021-2026) Table 76. Latin America Ophthalmic AAV Gene Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 77. Latin America Ophthalmic AAV Gene Therapy Market Share Forecast by Country (2027-2032) Table 78. Middle East & Africa Ophthalmic AAV Gene Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 79. Middle East & Africa Ophthalmic AAV Gene Therapy Market Size by Country (2021-2026) & (US$ Million) Table 80. Middle East & Africa Ophthalmic AAV Gene Therapy Market Share by Country (2021-2026) Table 81. Middle East & Africa Ophthalmic AAV Gene Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 82. Middle East & Africa Ophthalmic AAV Gene Therapy Market Share Forecast by Country (2027-2032) Table 83. Research Programs/Design for This Report Table 84. Authors List of This Report Table 85. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Ophthalmic AAV Gene Therapy Product Image Figure 3. Global Ophthalmic AAV Gene Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Ophthalmic AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 5. Global Ophthalmic AAV Gene Therapy Market Share by Region: 2025 VS 2032 Figure 6. Global Ophthalmic AAV Gene Therapy Market Share by Region (2021-2032) Figure 7. North America Ophthalmic AAV Gene Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Ophthalmic AAV Gene Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Ophthalmic AAV Gene Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Ophthalmic AAV Gene Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Ophthalmic AAV Gene Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Subretinal Injection Image Figure 13. Global Subretinal Injection Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Intravitreous Injection Image Figure 15. Global Intravitreous Injection Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Ophthalmic AAV Gene Therapy Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Ophthalmic AAV Gene Therapy Market Share by Type 2025 VS 2032 Figure 18. North America Ophthalmic AAV Gene Therapy Market Size Share by Type (2021-2032) Figure 19. Europe Ophthalmic AAV Gene Therapy Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Ophthalmic AAV Gene Therapy Market Size Share by Type (2021-2032) Figure 21. Latin America Ophthalmic AAV Gene Therapy Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Ophthalmic AAV Gene Therapy Market Size Share by Type (2021-2032) Figure 23. Retinopathy Image Figure 24. Global Retinopathy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Optic Atrophy Image Figure 26. Global Optic Atrophy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Global Ophthalmic AAV Gene Therapy Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Ophthalmic AAV Gene Therapy Market Share by Application 2025 VS 2032 Figure 29. North America Ophthalmic AAV Gene Therapy Market Size Share by Application (2021-2032) Figure 30. Europe Ophthalmic AAV Gene Therapy Market Size Share by Application (2021-2032) Figure 31. Asia-Pacific Ophthalmic AAV Gene Therapy Market Size Share by Application (2021-2032) Figure 32. Latin America Ophthalmic AAV Gene Therapy Market Size Share by Application (2021-2032) Figure 33. Middle East and Africa Ophthalmic AAV Gene Therapy Market Size Share by Application (2021-2032) Figure 34. Global Top 5 and 10 Ophthalmic AAV Gene Therapy Players Market Share by Revenue in 2025 Figure 35. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. North America Ophthalmic AAV Gene Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 37. North America Ophthalmic AAV Gene Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 38. North America Ophthalmic AAV Gene Therapy Market Share by Country (2021-2032) Figure 39. Europe Ophthalmic AAV Gene Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 40. Europe Ophthalmic AAV Gene Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 41. Europe Ophthalmic AAV Gene Therapy Market Share by Country (2021-2032) Figure 42. Asia-Pacific Ophthalmic AAV Gene Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. Asia-Pacific Ophthalmic AAV Gene Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. Asia-Pacific Ophthalmic AAV Gene Therapy Market Share by Country (2021-2032) Figure 45. Latin America Ophthalmic AAV Gene Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Latin America Ophthalmic AAV Gene Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Latin America Ophthalmic AAV Gene Therapy Market Share by Country (2021-2032) Figure 48. Middle East & Africa Ophthalmic AAV Gene Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Middle East & Africa Ophthalmic AAV Gene Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Middle East & Africa Ophthalmic AAV Gene Therapy Market Share by Country (2021-2032) Figure 51. Years Considered Figure 52. Research Process Figure 53. Key Executives Interviewed

Scope & coverage.

Types
  • Subretinal Injection
  • Intravitreous Injection
Applications
  • Retinopathy
  • Optic Atrophy
Companies covered
  • GenSight Biologics (Pipeline)
  • Spark/Roche (Luxturna)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Ophthalmic AAV Gene Therapy Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Ophthalmic AAV Gene Therapy Market Size by Region (2021-2032)
  5. 1.4.1 Global Ophthalmic AAV Gene Therapy Market Size by Region (2021-2026)
  6. 1.4.2 Global Ophthalmic AAV Gene Therapy Market Size by Region (2027-2032)
  7. 1.5 Key Regions Ophthalmic AAV Gene Therapy Market Size (2021-2032)
  8. 1.5.1 North America Ophthalmic AAV Gene Therapy Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Ophthalmic AAV Gene Therapy Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Ophthalmic AAV Gene Therapy Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Ophthalmic AAV Gene Therapy Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Ophthalmic AAV Gene Therapy Market Size Growth Rate (2021-2032)
2 Ophthalmic AAV Gene Therapy Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Subretinal Injection
  3. 2.1.2 Intravitreous Injection
  4. 2.2 Global Ophthalmic AAV Gene Therapy Market Size by Type
  5. 2.2.1 Global Ophthalmic AAV Gene Therapy Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Ophthalmic AAV Gene Therapy Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Ophthalmic AAV Gene Therapy Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Ophthalmic AAV Gene Therapy Market Size by Regions
  9. 2.3.1 North America Ophthalmic AAV Gene Therapy Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Ophthalmic AAV Gene Therapy Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Ophthalmic AAV Gene Therapy Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Ophthalmic AAV Gene Therapy Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Ophthalmic AAV Gene Therapy Market Size Breakdown by Type (2021-2026)
3 Ophthalmic AAV Gene Therapy Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Retinopathy
  3. 3.1.2 Optic Atrophy
  4. 3.2 Global Ophthalmic AAV Gene Therapy Market Size by Application
  5. 3.2.1 Global Ophthalmic AAV Gene Therapy Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Ophthalmic AAV Gene Therapy Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Ophthalmic AAV Gene Therapy Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Ophthalmic AAV Gene Therapy Market Size by Regions
  9. 3.3.1 North America Ophthalmic AAV Gene Therapy Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Ophthalmic AAV Gene Therapy Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Ophthalmic AAV Gene Therapy Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Ophthalmic AAV Gene Therapy Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Ophthalmic AAV Gene Therapy Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Ophthalmic AAV Gene Therapy Industry Trends
  2. 4.2 Ophthalmic AAV Gene Therapy Industry Drivers
  3. 4.3 Ophthalmic AAV Gene Therapy Industry Opportunities and Challenges
  4. 4.4 Ophthalmic AAV Gene Therapy Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Ophthalmic AAV Gene Therapy Revenue (2021-2026)
  2. 5.2 Global Ophthalmic AAV Gene Therapy Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Ophthalmic AAV Gene Therapy Key Company Headquarters & Area Served
  4. 5.4 Global Ophthalmic AAV Gene Therapy Company, Product Type & Application
  5. 5.5 Global Ophthalmic AAV Gene Therapy Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Ophthalmic AAV Gene Therapy Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Ophthalmic AAV Gene Therapy Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Ophthalmic AAV Gene Therapy Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 GenSight Biologics (Pipeline)
  2. 6.1.1 GenSight Biologics (Pipeline) Company Information
  3. 6.1.2 GenSight Biologics (Pipeline) Business Overview
  4. 6.1.3 GenSight Biologics (Pipeline) Ophthalmic AAV Gene Therapy Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 GenSight Biologics (Pipeline) Ophthalmic AAV Gene Therapy Product Portfolio
  6. 6.1.5 GenSight Biologics (Pipeline) Recent Developments
  7. 6.2 Spark/Roche (Luxturna)
  8. 6.2.1 Spark/Roche (Luxturna) Company Information
  9. 6.2.2 Spark/Roche (Luxturna) Business Overview
  10. 6.2.3 Spark/Roche (Luxturna) Ophthalmic AAV Gene Therapy Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Spark/Roche (Luxturna) Ophthalmic AAV Gene Therapy Product Portfolio
  12. 6.2.5 Spark/Roche (Luxturna) Recent Developments
7 North America
  1. 7.1 North America Ophthalmic AAV Gene Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Ophthalmic AAV Gene Therapy Market Size by Country (2021-2026)
  3. 7.3 North America Ophthalmic AAV Gene Therapy Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Ophthalmic AAV Gene Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Ophthalmic AAV Gene Therapy Market Size by Country (2021-2026)
  3. 8.3 Europe Ophthalmic AAV Gene Therapy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Ophthalmic AAV Gene Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Ophthalmic AAV Gene Therapy Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Ophthalmic AAV Gene Therapy Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Ophthalmic AAV Gene Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Ophthalmic AAV Gene Therapy Market Size by Country (2021-2026)
  3. 10.3 South America Ophthalmic AAV Gene Therapy Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Ophthalmic AAV Gene Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Ophthalmic AAV Gene Therapy Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Ophthalmic AAV Gene Therapy Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst